Elizabeth E. Evans - 11 May 2021 Form 3 Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Operating Officer
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Elizabeth Evans
Issuer symbol
VCNX
Transactions as of
11 May 2021
Net transactions value
$0
Form type
3
Filing time
21 May 2021, 17:03:21 UTC
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 9,600 11 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VCNX Stock Option (Right to Buy) 11 May 2021 Common Stock 9,610 $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 11 May 2021 Common Stock 8,605 $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) 11 May 2021 Common Stock 12,400 $3.90 Direct F2
holding VCNX Stock Option (Right to Buy) 11 May 2021 Common Stock 10,000 $3.82 Direct F3
holding VCNX Stock Option (Right to Buy) 11 May 2021 Common Stock 8,000 $2.93 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully exercisable as of the date of this report
F2 This option has vested with respect to 6,200 shares and the remainder vests in two equal annual installments beginning on March 15, 2022.
F3 This option has vested with respect to 2,500 shares and the remainder vests in three equal annual installments beginning on April 3, 2022.
F4 This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.